In South Africa, there are numerous governance structures that make crucial decisions about selection, procurement, distribution, and use of medicines, diagnostics, and other pharmaceutical products. A challenge commonly encountered is that critical committees either do not exist or where the committee is in place, it does not function optimally. One of the most underlying causes of poor functioning of committees is the absence of or weak terms of reference (TOR). In 2015, the Affordable Medicines Directorate (AMD) of South Africa’s National Department of Health (NDOH), requested assistance from SIAPS in strengthening the TOR of several national committees, including those involved in selection of medicines for inclusion on the National Essential Medicines List (NEML). SIAPS developed a TOR guidance document that can be used in the development or review of TOR. The purpose of this brief is to share the guidance document and the processes SIAPS and their counterparts followed to develop new and revise existing TOR for three different pharmaceutical sector committees in South Africa.
Archive | Policies and Strategic PlansRSS feed for this section
Developing Better Terms of Reference to Improve the Performance of Pharmaceutical Sector Committees: Case Studies from South Africa
Le Ministère de la santé guinéen a décidé d’élaborer un guide de renforcement de la surveillance en vue de consolider les acquis de la riposte contre d’éventuelles épidémies ainsi que la prise de mesures efficaces visant au relèvement du système de surveillance en Guinée. Outre les plans nationaux de distribution ordinaire élaborés, l’unité logistique, en collaboration avec ses partenaires, a élaboré un plan national de distribution d’urgence des intrants vers les structures périphériques en octobre 2015. Le plan a été validé et exécuté. Compte tenu des leçons tirées des précédentes opérations de distribution, il est important de faire suivre une supervision pour s’assurer de l’exécution correcte de l’opération.
Pour lutter contre le paludisme, le Ministère de la Santé à travers le Programme national de lutte contre le paludisme (PNLP) a élaboré un plan stratégique national de troisième génération couvrant la période allant de 2013 à 2017. Il a été approuvé en février 2014 lors de la signature de l’aide-mémoire de la revue de performance du PNLP. Pour réaliser cet important volet du PSN, le PNLP, en collaboration avec ses partenaires, a élaboré en octobre 2014 et amendé en 2016 une grille nationale de supervision formative intégrée. C’est dans cette optique que s’inscrit cette supervision formative intégrée dans les directions préfectorales de la santé de Labé et de Mali du 5 au 14 août 2016, qui doit déboucher sur l’élaboration des plans de résolution des problèmes identifiés au niveau des structures.
On June 8, 2017, SIAPS disseminated the Directorate General of Drug Administration’s (DGDA) five-year Strategic Plan (2017-2021) in the presence of the Honorable Major General Mohammad Mustafizur Rahman, Director General of DGDA. The dissemination of this plan is the result of a year-long process. In March 2016, WHO engaged with various stakeholders (SIAPS, USAID, the […]
A new collection of technical briefs highlight strategic approaches, innovations, results and lessons learned in implementing systems-wide interventions to strengthen pharmaceutical systems and services in three countries: South Africa, Namibia and Ethiopia. Click on the thumbnails below to read the full technical briefs. Strengthening Namibia’s Pharmacy Sector and Workforce Strengthening the Leadership and Management of […]
Developing a CMS strategic plan can help align pharmaceutical supply chain objectives with overall public-sector health supply chain strategies. It can help ensure that health commodities are readily available to health facilities through an uninterrupted supply chain; minimize waste and losses; improve business and financial growth; and respond to changes in the supply chain, such as new technologies and emerging markets. In addition, advocating for and encouraging stakeholders to assess the medicine supply chain system can increase interest in generating additional technical, financial, and material resources for health care. Supply chain interventions can also contribute to improving rational medicine use and strengthening pharmaceutical regulation.
Systems thinking is now a widely accepted concept in global health. Governments, donors, and other actors in global health recognize that guaranteeing the availability of medicines is a necessary, but insufficient component to improving health outcomes. Rather, medicines availability must be bolstered by other components, such as ensuring that quality medicines are available and prescribed and dispensed appropriately by health care workers; patients must also use medicines properly. In order to achieve improvements in health for their populations and address health inequities, governments and donors must invest in strengthening health systems. A health system depends on its subcomponent, a pharmaceutical system, for the continuous availability of safe, effective, and affordable essential medicines and other health technologies of assured quality to deliver effective health interventions that improve health outcomes. This is in alignment with USAID’s Vision for Health Systems Strengthening (2015-2019). To this end, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program focuses on achieving positive health outcomes by assuring the availability of quality pharmaceutical products and effective pharmaceutical services.
Technical Approach to Developing a Strategic Plan to Strengthen the Central Medical Store: The Case of Pharmacie Populaire du Mali
This document describes the techniques and experiences of and lessons learned from developing a strategic plan for the Pharmacie Populaire du Mali (PPM). Technical assistance providers, managers of pharmaceutical supply chain organizations, and consultants can adapt this information to suit local contexts and needs and apply it to their own public health pharmaceutical supply chain strategic plans.
SIAPS employed a systematic and structured approach to support PPM in developing its first strategic plan, including defining the scope and refining the task of developing a strategic plan through consultation with key stakeholders; conducting a national supply chain situational analysis that included country context–political, environmental, social, legislative, economic, and ethical factors–identifying gaps between the organization’s mission and vision and the expectations of clients and stakeholders; prioritizing and developing strategic objectives; and action planning and budgeting.
Global partnerships and new models of TB care are crucial to success in the fight against multidrug-resistant tuberculosis (MDR-TB), according to speakers at a panel discussion on the White House National Action Plan for Combating MDR-TB. The plan, which was released in December, aims to treat 35% of all MDR-TB patients in the 10 countries with the highest TB burden […]
From the development of sound policies and legislation, to the selection, procurement, and distribution of medicines; governance issues permeate all levels of the pharmaceutical sector and heavily influence the availability and accessibility of medicines and other health commodities. The USAID-funded SIAPS project is pleased to announce the launch of a new course on USAID’s Global Health […]
Join us for our new webinar on Tuesday, October 24, at 12:00 pm EST to learn more about SIAPS’ approach […]
Despite being one of the most densely populated countries in the world, the overall health in Bangladesh has steadily improved […]
The Philippines has one of the highest TB burdens in the world—and 2.6% of its more than 286,000 new cases […]